Rathbones Group PLC, a registered investment adviser, initiated a new position in Eli Lilly and Company (NYSE:LLY) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 392,154 shares of the Healthcare company, valued at approximately $421,440,060 as of the filing date.
Eli Lilly and Company's stock currently trades at $1057.85 with a market capitalization of $906,495,985,887.